Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kyle G. Mitchell
Institution:
The University of Texas MD Anderson Cancer Center
Observed institution:
The University of Texas MD Anderson Cancer Center
OpenAlex ID:
A5138009840
Outcomes of Lobectomy vs Sublobar Resection for Clinical Stage IA3 Non-Small Cell Lung Cancer
2026
·
Zamaan Hooda
, Shanique Ries
, et al.
·
The Annals of Thoracic Surgery
·
2
Outcomes Of Neoadjuvant Chemoradiation Vs Neoadjuvant Chemotherapy for Esophageal Junction Signet Ring Cell Adenocarcinoma
2026
·
Zamaan Hooda
, Dylan Langburt
, et al.
·
The Annals of Thoracic Surgery
·
1
Using Induction Chemoimmunotherapy as a Bridge to Definitive Local Therapy for Non-Metastatic NSCLC: Real-World Outcomes From a Comprehensive Cancer Center
2026
·
Troy J. Kleber
, Sage A. Copling
, et al.
·
Clinical Lung Cancer
Local Control, Global Strategy: Rethinking the Goals of Surgery for Mesothelioma
2026
·
Mariya L. Samoylova
, Kyle G. Mitchell
·
The Annals of Thoracic Surgery
PP01.57: Are Bone Metastases A Contraindication? Role of Surgical Consolidation in EGFR-Mutated Stage IV NSCLC Patients Receiving Osimertinib
2026
·
Zamaan Hooda
, Ana McCracken
, et al.
·
Journal of Thoracic Oncology
Outcomes of Thoracic Surgical Oncology Group 103: Multimodality management in risk-stratified patients with lung-limited metastatic colorectal cancer
2026
·
Mara B. Antonoff
, Zamaan Hooda
, et al.
·
JTCVS Open
Imaging predictors of pleural response in stage IV non–small cell lung cancer
2026
·
Nicolas Zhou
, Ioannis Vlahos
, et al.
·
JTCVS Open
The North American Experiences
2026
·
Nicolas Zhou
, Kyle G. Mitchell
, et al.
·
Springer eBooks
Show more works
View as search
Works count:
8
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type